StructureMoaOncology · CNS · cardio-metabolic · ADC catalog

Drug · GLP-1 / incretin · GLP-1 / incretin · Sourced compound

Tirzepatide structure · mechanism

PubChem CID 166567236. Molecular formula C225H348N48O68. Independently assigned structure; reviewed 2026-10-08. Family grouping is editorial and does not establish shared activity.

Molecular structure from independently sourced SMILES

Tirzepatide 2D structure

Role
Drug
Mechanism class
GLP-1 / incretin
InChIKey
BTSOGEDATSQOAF-MCNPHUAVSA-N
Structure checked
2026-10-08
Molecular formula
C225H348N48O68
Structure source
PubChem
PubChem CID
166567236
InChI Key
BTSOGEDATSQOAF-MCNPHUAVSA-N
FDA / EMA
FDA/EMA
ClinicalTrials.gov
tirzepatide obesity

How similarity is calculated

SMILES

CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N5CCC[C@H]5C(=O)N6CCC[C@H]6C(=O)N7CCC[C@H]7C(=O)N[C@@H](CO)C(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)C(C)(C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CC8=CC=C(C=C8)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC9=CC=CC=C9)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@H](CC1=CC=C(C=C1)O)N

Tags

GLP-1GIPdual-agonistobesity

Related compounds

  • ExenatideSimilarity · Tanimoto 0.67 · DrugSourced compound
  • LiraglutideSimilarity · Tanimoto 0.60 · DrugSourced compound
  • SemaglutideSimilarity · Tanimoto 0.72 · DrugSourced compound
  • SurvodutideSimilarity · Tanimoto 0.59 · DrugSourced compound

External IDs · BioMoa

PubChem CID 166567236ChEMBLBioMoa · Mounjaro / ZepboundBioMoa bridgeOpen on the family mapFlowStructure tableMechanism class

StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Methodology

Editorial responsibility and corrections

Operated and edited by the independent StructureMoa project. Explanations use AI assistance; structural identity and similarity are checked against source records and calculation tests. Molecular data and clinical or regulatory evidence have separate review scopes.

Source structures
PubChem · CID / SMILES / InChIKey
Calculations and automated checks
RDKit · Morgan / SMARTS
Disclosed specialist review
No separate external specialist review is disclosed. Passing automated tests is not specialist review of clinical claims.

For a correction, include the page URL, molecule name or CID, the field in question and a supporting source. Corrections are checked against sources, and the affected editorial update date is changed when a correction is published. [email protected]